Screener
Johnson & Johnson JNJ Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Johnson & Johnson in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000200406-26-000153
| Line item | June 28, 2026 | December 28, 2025 |
|---|---|---|
| Accounts payable | 9,223 | 11,991 |
| Accrued liabilities | 9,464 | 8,594 |
| Accrued rebates, returns and promotions | 19,990 | 19,124 |
| Accrued compensation and employee related obligations | 3,475 | 4,534 |
| Accrued taxes on income (Note 5) | 1,051 | 1,388 |
| Total current liabilities | 54,895 | 54,126 |
| Long-term debt (Note 4) | 37,344 | 39,438 |
| Deferred taxes on income (Note 5) | 6,608 | 6,791 |
Item 1 — Financial statements
FAQ
- What is Johnson & Johnson's accrued manufacturing costs?
- Johnson & Johnson (JNJ) reported accrued manufacturing costs of $3.48B in Q2 2026.
- How has Johnson & Johnson's accrued manufacturing costs changed year-over-year?
- Johnson & Johnson's accrued manufacturing costs increased by 5.4% year-over-year, from $3.3B to $3.48B.
- What is the long-term trend for Johnson & Johnson's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Johnson & Johnson's accrued manufacturing costs has grown at a 5.4% compound annual growth rate (CAGR), from $3.48B to $4.53B.
Ask your AI about Johnson & Johnson's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude